The HIV Netherlands Australia Thailand research collaboration: Lessons from 7 years of clinical research

AIDS

Volumn 18, Issue 15, 2004, Pages 1971-1978

  Safreed Harmon, Kelly ^a   Cooper, David A ^b   Lange, Joep M A ^c,d   Duncombe, Chris ^a   Phanuphak, Praphan ^e  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d International Antiviral Therapy Evaluation Centre (IATEC)   (Netherlands)

^e CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Antiretroviral therapy; Clinical trials; Developing countries; HIV; Research; Thailand

Indexed keywords

ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; NANDROLONE DECANOATE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RECOMBINANT INTERLEUKIN 2; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ACHIEVEMENT; AUSTRALIA; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG COST; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MEDICAL SOCIETY; MULTIDRUG RESISTANCE; NETHERLANDS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; THAILAND;

AUSTRALIA; BIOMEDICAL RESEARCH; CLINICAL TRIALS; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; NETHERLANDS; THAILAND;

EID: 7744237255     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200410210-00001     Document Type: Editorial

References (9)

1. Palella F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
2. UNAIDS. Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS; 2002.
3. UNAIDS. HIV-NAT: the HIV Netherlands Australia Thailand Research Collaboration - a Model for HIV-AIDS Clinical Research in a Developing Country. UNAIDS Best Practice Collection. Geneva: UNAIDS; July, 2000.
4. Kroon ED, Ungsedhapand C, Ruxrungtham K, Chuenyam M, Ubolyam S, Newell ME, et al. A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). AIDS 2000, 14:1349-1356.
5. Ruxrungtham K, Kroon ED, Ungsedhapand C, Teeratakulpisarn S, Ubolyam S, Buranapraditkun S, et al. A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients. AIDS 2000, 14:1375-1382.
6. Ruxrungtham K, Suwanagool S, Tavel JA, Chuenyam M, Kroon E, Ubolyam S, et al. A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand. AIDS 2000, 14:2509-2513.
7. Ananworanich J, Nuesch R, Le Braz M, Chetchotisakd P, Vibhagool A, Wicharuk S, et al. Failures of one week on, one week off anti-retroviral therapies in a randomized trial. AIDS 2004, in press.
8. Ministry of Public Health (Thailand). Update of the National Guidelines for the Clinical Management of HIV Infection in Children/Adults, 6th edn. Nonthaburi, Thailand: Ministry of Public Health; 2000.
9. International HIV Treatment Access Coalition. http://www. itacoalition.org (accessed 1 August, 2003).